TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Rechon Life Science AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
326,389
|
259,442
|
222,248 |
| Financial expenses |
2,102
|
866
|
765 |
| Earnings before taxes |
37,902
|
40,264
|
21,277 |
| EBITDA |
52,863
|
52,013
|
31,452 |
| Total assets |
244,707
|
218,478
|
206,264 |
| Current assets |
137,686
|
112,442
|
97,732 |
| Current liabilities |
67,757
|
53,338
|
38,673 |
| Equity capital |
136,324
|
113,378
|
95,114 |
| - share capital |
18,499
|
18,404
|
20,026 |
| Employees (average) |
249
|
212
|
184 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
55.7%
|
51.9%
|
46.1% |
| Turnover per employee |
1,311
|
1,224
|
1,208 |
| Profit as a percentage of turnover |
11.6%
|
15.5%
|
9.6% |
| Return on assets (ROA) |
16.3%
|
18.8%
|
10.7% |
| Current ratio |
203.2%
|
210.8%
|
252.7% |
| Return on equity (ROE) |
27.8%
|
35.5%
|
22.4% |
| Change turnover |
65,611
|
55,196
|
-959 |
| Change turnover % |
25%
|
27%
|
0% |
| Chg. No. of employees |
37
|
28
|
9 |
| Chg. No. of employees % |
17%
|
15%
|
5% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.